QA: Jazz Pharmaceuticals plc in us_pharma/2025

Table of Contents

See also this year's filing and all EDGAR filings for this company.

PDF Report 0001232524_2026_Jazz_Pharmaceuticals_plc.pdf

Logs

Graph

Absolute values for 0001232524, Jazz Pharmaceuticals plc

  xvar xval
0 AssetsCurrent 4,166,043,000
1 IntangibleAssetsNetIncludingGoodwill 6,258,850,000
2 PropertyPlantAndEquipmentNet 0
3 remainder_Assets 1,234,447,000
4 LiabilitiesCurrent 2,242,521,000
5 LiabilitiesNoncurrent 0
6 remainder_Liabilities 0
7 CostOfGoodsAndServicesSold 0
8 SellingGeneralAndAdministrativeExpense 1,947,058,801
9 ResearchAndDevelopmentExpense 1,537,062,554
10 remainder_Expenses 879,549,032
11 remainder_Revenues 4,638,903,055
12 remainder_NetIncome -175,096,135
13 remainder_ComprehensiveNetIncome 190,918,784
  yvar yval
0 Assets 11,659,340,000
1 Liabilities 2,242,521,000
2 Expenses 4,363,670,387
3 Revenues 4,638,903,055
4 StockholdersEquity 9,416,819,000
5 NetIncome 100,136,533
6 ComprehensiveNetIncome 195,595,925
7 BaseVar 11,635,224,680
8 EconomicCapitalRatiobeforeLimitedLiability 2.98
9 EconomicCapitalRatio 3.67

Edgar->Model Mapping

Feature Distribution

Change over Time